Immunovia realigning Swedish operations with strategic priorities and its focus on the US commercialization of the IMMray™ PanCan-d test

LUND, Sweden, Jan. 19, 2023 /PRNewswire/ — Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world’s first blood test dedicated to the early detection of pancreatic cancer, today announced it is realigning its Swedish operations with its strategic…